AAAAAA

   
Results: 1-8 |
Results: 8

Authors: Kiji, J Okano, T Nomura, T Saiki, K Sai, T Tsuji, J
Citation: J. Kiji et al., Mechanistic studies on Pd-catalyzed telomerization and co-cyclization of butadiene: Amphiphilicity of bis-pi-allylpalladium intermediate in the presence of phosphine ligand, B CHEM S J, 74(10), 2001, pp. 1939-1945

Authors: Itoh, K Ohtsu, T Sasaki, Y Ogura, M Morishima, Y Kasai, M Chou, T Yoshida, K Ohno, T Mizorogi, F Uike, N Sai, T Taniwaki, M Ikeda, S Tobinai, K
Citation: K. Itoh et al., Randomized comparison of mobilization kinetics of circulating CD34+cells between biweekly CHOP and dose-escalated CHOP with the prophylactic use of lenograstim (glycosylated rHuG-CSF) in aggressive non-Hodgkin's lymphoma, LEUK LYMPH, 38(5-6), 2000, pp. 521-532

Authors: Okamoto, H Nishizawa, T Tawara, A Takahashi, M Kishimoto, J Sai, T Sugai, Y
Citation: H. Okamoto et al., TT virus mRNAs detected in the bone marrow cells from an infected individual, BIOC BIOP R, 279(2), 2000, pp. 700-707

Authors: Okamoto, H Takahashi, M Nishizawa, T Tawara, A Sugai, Y Sai, T Tanaka, T Tsuda, F
Citation: H. Okamoto et al., Replicative forms of TT virus DNA in bone marrow cells, BIOC BIOP R, 270(2), 2000, pp. 657-662

Authors: Kobayashi, T Tobinai, K Shimoyama, M Mikuni, C Konda, S Kozuru, M Araki, K Sai, T Fukuhara, S Matsumoto, M Aoki, I Deura, K Oyama, A Hotta, T Abe, T Toki, H Nagai, M Fukuda, H Niimi, M Yamaguchi, N Tajima, K Shirakawa, S
Citation: T. Kobayashi et al., Long-term follow-up results of adult patients with acute lymphocytic leukemia or lymphoblastic lymphoma treated with short-term, alternating non-cross-resistant chemotherapy: Japan Clinical Oncology Group Study 8702, JPN J CLIN, 29(7), 1999, pp. 340-348

Authors: Takenaka, T Shirakawa, S Mikuni, C Sai, T Shimamoto, Y Araki, K Hirano, M Miura, A Ohno, Y Ichimaru, M Hanada, S Inaba, S Konishi, H Toki, H Tajima, K Niimi, M Fukuda, H Shimoyama, M
Citation: T. Takenaka et al., Alternating combination chemotherapy COP (cyclophosphamide, vincristine, prednisone) and MP (melphalan, prednisone) in multiple myeloma: a multicenter phase II study (JCOG8906), JPN J CLIN, 29(10), 1999, pp. 485-489

Authors: Sai, T Mine, M Fukuoka, M Koarada, S Kimoto, M
Citation: T. Sai et al., A mutational analysis of the A beta(z)/A alpha(d) major histocompatibilitycomplex class II molecule that restricts autoreactive T cells in (NZB x NZW)F1 mice. The critical influence of alanine at position 69 in the A alpha(d) chain, IMMUNOLOGY, 96(3), 1999, pp. 325-332

Authors: Mine, M Koarada, S Sai, T Miyake, K Kimoto, M
Citation: M. Mine et al., Peptide-binding motifs of the mixed haplotype A beta(z)/A alpha(d) major histocompatibility complex class II molecule: a restriction element for auto-reactive T cells in (NZBxNZW)F-1 mice, IMMUNOLOGY, 95(4), 1998, pp. 577-584
Risultati: 1-8 |